Sign in

CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843199512
Phone
(214) 612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
  1. 424B5 Offering Prospectus
  2. 424B5 Offering Prospectus
  3. 424B5 Offering Prospectus
  4. 424B5 Offering Prospectus
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. UPLOAD Other SEC-generated Letter
  8. S-3 Offering Registration Statement
  9. 424B5 Offering Prospectus
  10. 424B5 Offering Prospectus
  11. 424B3 Offering Prospectus
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. UPLOAD Other SEC-generated Letter
  14. S-3 Offering Registration Statement
  15. 424B3 Offering Prospectus
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. UPLOAD Other SEC-generated Letter
  18. S-3 Offering Registration Statement
  19. 424B5 Offering Prospectus
  20. 424B5 Offering Prospectus

Page 1 of 2 · 36 filings